Welcome to the newest members of the team

December 21, 2022

Welcome to the newest members of the team

Welcome to the newest members of the team

As development activities for both moxidectin and CC-11050 have accelerated, so has the need for additional staff to support those efforts. We are very pleased to announce the arrival of three new members of the Medicines Development for Global Health family:

Dr Mupenzi Mumbere: Senior Clinical Project Manager

Mupenzi began his new role in November 2022. Based in Butembo, Democratic Republic of Congo, Mupenzi is the new clinical project manager for the ongoing moxidectin in onchocerciasis clinical studies in the country.

Mupenzi joins Medicines Development for Global Health with a wealth of experience as a physician and clinical researcher, including as co-investigator in the Phase 3 trial of Moxidectin from 2010-2013 in Butembo. He received post graduate training in clinical development and clinical project management through a WHO/TDR Clinical Development Fellowship at GlaxoSmithKline in Belgium, working on a Phase 3 malaria vaccine clinical trial.

Mupenzi is passionate about eliminating neglected tropical diseases as a public health problem, and the potential of moxidectin to alleviate the burden of onchocerciasis and other parasitic diseases on communities in his region.

Mupenzi holds a degree in Medicine/Paediatrics.

Sophie Weston: Implementation Project Manager

Sophie joined Medicines Development for Global health in October 2022 and is managing the planning for the implementation of pilot field studies for moxidectin in onchocerciasis.

Sophie joins the company after working as Technical Lead for the Therapeutic Goods Administration and Department of Foreign Affairs and Trade, supporting Covid-19 vaccines access and roll-out across the Asia Pacific, working with World Health Organization and other agencies. Sophie has co-ordinated large international research projects working in the Northern Territory with the Menzies School of Health Research and in supporting implementation of the Australasian Covid-19 trial (ASCOT).

Sophie has a diverse experience that will inform and provide ideal support for field implementation projects with moxidectin, the next step towards wider field use of moxidectin to accelerate elimination efforts for onchocerciasis.

Sophie is a registered nurse with specialist and post-graduate training and a Master of Public Health, with experience ranging from teaching hospitals to rural and remote placements.

Vidya Uprety as Senior Clinical Project Manager

Vidya joined Medicines Development for Global Health in August 2022 and is the clinical project manager for the moxidectin in scabies Phase 2b study [MDGH-MOX-2002]. Vidya brings more than 15 years of clinical research experience, and having direct experience in site management, monitoring, trial management and vendor oversight across Phase 1 to Phase 3 clinical trials.

He has previously worked in resource limited settings in India and has a background of working in neglected tropical diseases. Most recently, Vidya worked with an Australian Clinical Research Organisation, managing multiple global studies and monitoring teams.

Vidya has a BSc in Chemistry and Post Graduate diploma in Clinical Research and Data Management as well as Project Management PMD Pro Level 1 certification.